German manufacturer of bioabsorbable orthopedic metal implants, Syntellix, inaugurated a production site in Singapore’s Tuas Biomedical Park on 10 September 2019. The manufacturing facility hosts the first dry CNC processing of highly advanced magnesium alloys ever performed anywhere in Asia, making Singapore a supply hub for the whole of Asia.
The company’s implants based on a patented magnesium alloy, dissolve completely in the bone. They degrade in the human body, and are converted into bone tissue. Unlike conventional metal implants, the patient does not have to undergo a second surgery to remove the implants.
Syntellix implants have product registrations in 56 countries worldwide, including Singapore. They have been successfully used in leading hospitals locally including National University Hospital, Singapore General Hospital, Sengkang General Hospital, Gleneagles, Mount Elizabeth Orchard, KK Women and Children’s Hospital, Farrer Park Hospital and Aptus Surgery Centre. The company’s products have also been introduced in Indonesia and Vietnam and successful surgeries have been conducted in Jakarta, Hanoi and Ho Chi Minh City. Syntellix has also established subsidiaries in India and the Philippines to tap the potential of those markets from the Singapore hub.
(Sources: Syntellix; Straits Times)
